Signaturefd, LLC Tarsus Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$11.57 - $19.63 $6,618 - $11,228	572 New	572 $10,000
Q4 2022 Jan 27, 2023	SELL	$14.12 - $18.72 $2,979 - $3,949	-211 Reduced 94.2%	13 $0
Q3 2022 Nov 08, 2022	BUY	$14.08 - $18.5 $3,153 - $4,144	224 New	224 $4,000
Q3 2021 Oct 28, 2021	SELL	$21.45 - $29.22 $579 - $788	-27 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$27.16 - $38.59 $733 - $1,041	27 New	27 $1,000

170

43.3M

484K

4.1K

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.4B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.